NOVABIOTICS

NovaBiotics Ltd is a clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat, medically unmet diseases. The Company’s robust pipeline includes clinical stage antimicrobials that have been derived from NovaBiotics’ proprietary anti-infective peptide platform and a “mini biologic” antibacterial-mucolytic compound (Lynovex®). NovaBiotics lead product, NP213 (Novexatin®) is being developed as a topical treatment for fungal nail infections (onychomycosis), a condition that affects more than 10% of the global population. In 2014, NP213 will undergo evaluation in Phase IIb clinical trials with the Company’s co-development partner, Taro Pharmaceuticals.

#SimilarOrganizations #People #Financial #Website #More

NOVABIOTICS

Social Links:

Twitter

Industry:

Biotechnology Clinical Trials Medical Therapeutics

Founded:

2004-01-01

Address:

Aberdeen, Aberdeen City, United Kingdom

Country:

United Kingdom

Website Url:

http://www.novabiotics.co.uk

Total Employee:

11+

Status:

Active

Contact:

+4401224711377

Email Addresses:

[email protected]

Total Funding:

10.9 M GBP

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics